[1] Sartor O. Radioisotopic treatment of bone pain from metastatic prostate cancer. 2003. doi:10.1007/s11912-003-0119-2
[2] Xu J, YANGRN, ZENG X J. The management of thyroid well-differentiated carcinoma invading the upper aerodigestive tract. 中华肿瘤杂志2003(5)
[3] BRACHMAN D G, THOMAS T, HILBE J. Failure-free survival following brachytherapy alone or external beam irradiation alone for T 1-2 prostate tumors in 2222 patients:results from a single practice. 2000(1). doi:10.1016/S0360-3016(0)00598-8
[4] MONTEBELLO J F, PAPIEZ L, SIDDIQUI A R. Contamination of the pleural surfaces in childhood sarcoma.Use of colloidal P-32 to reduce radiation dose to the whole lung, 1997
[5] Stewart J S, HIRD V, SNOOK D. Intraperitoneal 131 I-and 90 Y-labelled monoclonal antibodies for ovarian cancer: pharmacokinetics and normal tissue dosimetry. 1988(ZK). doi:10.1002/ijc.2910410815
[6] Jurcic J G, LARSON S M, SGOUROS G. Targeted alpha particle immunotherapy for myeloid leukemia. 2002
[7] Yu J, HAFELI U O, SANDS M. 90 Y-oxine-ethiodol,a potential radiopharmaceutical for the treatment of liver cancer. 2003(5). doi:10.1016/S0969-8043(3)00064-2
[8] NOVAK-HOFER I, SCHUBIGER P A. Copper-67 as a therapeutic nuclide for radioimmunotherapy. 2002
[9] Iznaga-Escobar N. 188 Re-direct labeling of monoclonal antibodies for radioimmunotherapy of solid tumors:biodistribution,normal organ dosimetry,and toxicology. 1998(5). doi:10.1016/S0969-8051(98)00008-0
[10] Chakraborty S, DAS T, UNNI P R. 177 Lu labeled polyaminophosphonates as potential agents for bone pain palliation. 2002(1). doi:10.1097/00006231-200201000-00011
[11] SELDIN W. Techniques for using bexxar for the treatment of non-Hodgkin's lymphoma. 2002
[12] Mc DEVITT M R, MA D, LAI L T. Tumour therapy with targeted atomic nanogrnrrators. 2001(5546). doi:10.1126/science.1064126
[13] Song H, YANCH J C, KLINKOWSTEIN R E. Accelerator-based neutron brachytherapy. 2002(1). doi:10.1118/1.1427308
[14] FANG A Y, AMOLS H I, ZAIDER M. Optimized planning for intraoperative planar permanent-seed implant. 2002. doi:10.1120/1.1491787
[15] Chen Z, NATH R. Biologically effective dose (BED)for interstitial seed implants containing a mixture of radionuclides with different half-lives, 2003 |
